To pharmaceutical majors, the 2021 NRDL brings about triumphs for many, disappointments to some, and high dramas and suspense for all. As the dust finally settles, it is time for pharmaceutical companies to take time to refresh, reflect, and revisit their China access strategy as needed, and ...